Pharmaceuticals: Farmindustria, Bruno confirmed as president of the CDM for 2021-2023

Giorgio Bruno has been confirmed as president of the Cdmo-Specialists Group of Pharmaceutical Manufacturing of Farmindustria for the two-year period 2021-2023. It is the fourth mandate at the helm of the Group which brings together pharmaceutical companies specialized in the production, control and development of drugs, carried out on commission from the companies holding the marketing authorization. “We are a model of excellence in a leading sector such as pharmaceuticals”, says Giorgio Bruno. “The Cdmo (Contract development and manufacturing organization) made in Italy continues to remain first in the EU for value of production, with 2.3 billion euros, ahead of Germany (2.1 billion euros) and France (1.9 billion of Euro). And it represents an important component in continuing to make medicines available, even in complex moments like the one we are experiencing. Thanks to highly specialized human resources, a high know-how of products and processes and cutting-edge technologies, the 21 companies of our group are characterized by an undisputed quality of production. Companies that – among other things – are at the forefront in some production phases of vaccines against Covid-19, and in the production of treatments that can be used in Covid-19 patients (from innovative monoclonal antibodies, to established therapies, such as corticosteroids and heparins) “.” The reappointment to the presidency of the Cdmo Group is an honor for me – concludes Bruno – but it is first and foremost a team success for all the companies that demonstrate the great cohesion and vitality of this sector “.